A

Abe Abraham

About

Detail

Co-Founder & Chief Medical Officer
San Diego, California, United States

Timeline


work
Job
school
Education
folder
Project
auto_stories
Publication

Résumé


Jobs verified_user 0% verified
  • F
    Founder, COO, Chief Medical Officer
    Nov 2024 - Current (1 year 8 months)
  • Neurocrine Biosciences
    Senior Medical Director
    Neurocrine Biosciences
    Mar 2024 - Nov 2024 (9 months)
  • Novellia
    Co-Founder & Chief Medical Officer
    Novellia
    Mar 2022 - Current (4 years 4 months)
  • Alladapt Immunotherapeutics Inc
    Head of Clinical Development
    Alladapt Immunotherapeutics Inc
    Sep 2019 - Mar 2022 (2 years 7 months)
  • Genentech
    Senior Medical Director, Immunology
    Genentech
    Sep 2018 - Sep 2019 (1 year 1 month)
    Actemra (Tocilizumab) - US Medical Lead
  • Genentech
    Medical Director, Immunology
    Genentech
    Oct 2017 - Aug 2018 (11 months)
    Actemra (Tocilizumab) - US Medical Lead; anti-CD20/BTK-i US Medical Lead
  • Genentech
    Associate Medical Director, Immunology
    Genentech
    Mar 2015 - Oct 2017 (2 years 8 months)
    Actemra (Tocilizumab)
  • Bristol Myers Squibb
    R&D Strategy and Business Operations Summer Intern
    Bristol Myers Squibb
    Jun 2014 - Aug 2014 (3 months)
    • Developed and analyzed cost/benefit data from learning needs analysis and spending reports in R&D to help create benchmark learning strategy across drug development spectrum • Designed Immunology/Virology training course in concert with University of Connecticut to help fill development need in R&D • Facilitated reorganization of Physician Career Connection initiative to engage and retain physician talent within all therapeutic areas
  • Cognuse
    Advisory Board Member, Healthcare Strategy
    Cognuse
    Feb 2014 - Jun 2014 (5 months)
    • Advised on clinical research strategy for clinical trials and determine best practices for potential partnership agreements with Johns Hopkins Medicine • Presented biotechnology investment opportunity to investors and partners including Baltimore Angels and Scripps Health Hospitals
  • University of Chicago
    Postdoctoral Clinical Research Fellow
    University of Chicago
    May 2010 - Jul 2013 (3 years 3 months)
    • Recruited over 100 participants for clinical research projects by implementing optimized recruitment strategy • Analyzed data to develop trend reports and early stage cost benefit analysis for biotechnology firm investigating medical device impact on Type II Diabetes versus medication. • Developed manuscripts on current projects and future research proposals • Supervised clinical research meetings with weekly reporting to department chair to address research challenges and sustainable solutions.
  • University of Chicago
    Clinical Research Coordinator
    University of Chicago
    Aug 2009 - Apr 2010 (9 months)
    • Managed clinical research study investigating relationship between slow wave sleep suppression and obesity • Responsible for enrollment, informed consent, site monitoring and handling adverse events • Developed weekly coordinator meetings for research projects to revise ongoing protocols to ensure clean data collection and analysis
  • I
    Coordinator/Instructor
    Indian Institute of Emergency Medical Services
    Nov 2005 - May 2013 (7 years 7 months)
    • Organized American Heart Association Advanced Care Life Support/Basic Life Support courses for healthcare professionals • Coordinated gratis life saving skills courses for local communities throughout India • Served as Basic Life Support instructor for healthcare professional courses and community life saving skills courses
Education verified_user 0% verified
  • The Johns Hopkins University  Carey Business School
    Master of Business Administration (MBA, Health Care Management / Enterprise Risk Management
    The Johns Hopkins University Carey Business School
    Jan 2013 - Dec 2015 (3 years)
  • University of Chicago
    Postdoctoral Clinical Research Fellowship, Pulmonology/Endocrinology/Sleep Medicine
    University of Chicago
    Jan 2009 - Dec 2013 (5 years)
  • S
    Doctor of Medicine (MD, Medicine
    St Christopher IMD College of Medicine
    Jan 2000 - Dec 2009 (10 years)
  • Howard University
    Bachelor of Science (B.S, Biology/Biological Sciences, General
    Howard University
    Jan 2000 - Dec 2004 (5 years)
  • S
    Doctor of Medicine (MD, Medicine
    St Christopher IMD College of Medicine
Projects (professional or personal) verified_user 0% verified
  • I
    Innovation for Humanity: Hospital Padre Carollo, Quito, Ecuador
    Sep 2013 - Mar 2014 (7 months)
    • Conduct detailed financial analysis in order to develop strategy recommendations for revenue generation in emerging market universal healthcare system (Hospital Padre Carollo in Quito, Ecuador) • Risk sharing model development for hospital and insurance agreements to foster continued growth • Restructured asset financing plan to help decrease hospital liability and increase return on investment in shorter time period • Development of Occupational Health Department to re-position hospital as central preventive care organization serving all of South Ecuador • Development and administration of detailed market research analysis to create marketing strategy to retain current low income patients and target higher income patient population
Publications verified_user 0% verified
  • D
    Sleep Restriction Increases Free Fatty Acids in Healthy Men
    Diabetologia
    Feb 2015
    Abstract AIMS/HYPOTHESIS: Sleep loss is associated with insulin resistance and an increased risk for type 2 diabetes, yet underlying mechanisms are not understood. Elevation of circulating non-esterified (i.e. free) fatty acid (NEFA) concentrations can lead to insulin resistance and plays a central role in the development of metabolic diseases. Circulating NEFA in healthy individuals shows a marked diurnal variation with maximum levels occurring at night, yet the impact of sleep loss on NEFA levels across the 24 h cycle remains unknown. We hypothesised that sleep restriction would alter hormones that are known to stimulate lipolysis and lead to an increase in NEFA levels. RESULTS: Sleep restriction relative to normal sleep resulted in incre
  • E
    Effective CPAP Treatment of Obstructive Sleep Apnea Improves Glycemic Control in Type 2 Diabetics.
    Tasali E, Abraham V, Aronsohn R, Dronavalli S, Pamidi S, Touma C, Whitmore H, Mohklesi B, Van Cauter E. Effective CPAP Treatment of Obstructive Sleep Apnea Improves Glycemic Control in Type 2 Diabetics. Submitted for Associated Professional Sleep Society Sleep 2012 Annual Meeting.
  • G
    Glucose Metabolism and Sleep Apnea in Young Lean Men.
    Pamidi S, Kazsa K, Broussard J, Day A, Hanlon E, Abraham V, Tasali E. Glucose metabolism and sleep apnea in young lean men. Diabetes Care. 2012 Aug 21.
  • I
    Impact of Obstructive Sleep Apnea on Insulin Secretion and Action in Healthy Young Lean Men.
    Pamidi S, Kazsa K, Broussard J, Day A, Hanlon E, Abraham V, Tasali E. Impact of obstructive sleep apnea on insulin secretion and action in healthy young lean men. American Thoracic Society 2012 Annual Meeting.
  • I
    Increased Food Intake After Sleep Curtailment: Roles of Ghrelin and Pancreatic Polypeptide
    Tasali E, Broussard J, Delebecque F, Day A, Abraham V, Kilkus J and Van Cauter E. Increased food intake after sleep curtailment: Roles of ghrelin and pancreatic polypeptide. 2010 Annual Meeting of the International Congress of Neuroendocrinology.
This is a community-created genome.